1. Canagliflozin for the treatment of adults with Type 2 diabetes. (May 2015) Authors: Meininger, Gary; Canovatchel, William; Polidori, David; Rosenthal, Norm Journal: Diabetes management Issue: Volume 5:Number 3(2015) Page Start: 183 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Canagliflozin: a sodium glucose co‐transporter 2 inhibitor for the treatment of type 2 diabetes mellitus. Issue 1 (25th August 2015) Authors: Rosenthal, Norm; Meininger, Gary; Ways, Kirk; Polidori, David; Desai, Mehul; Qiu, Rong; Alba, Maria; Vercruysse, Frank; Balis, Dainius; Shaw, Wayne; Edwards, Robert; Bull, Scott; Di Prospero, Nicholas; Sha, Sue; Rothenberg, Paul; Canovatchel, William; Demarest, Keith Journal: Annals of the New York Academy of Sciences Issue: Volume 1358:Issue 1(2015) Page Start: 28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cardiovascular and Renal Outcomes With Canagliflozin According to Baseline Kidney Function: Data From the CANVAS Program. Issue 15 (9th October 2018) Authors: Neuen, Brendon L.; Ohkuma, Toshiaki; Neal, Bruce; Matthews, David R.; de Zeeuw, Dick; Mahaffey, Kenneth W.; Fulcher, Greg; Desai, Mehul; Li, Qiang; Deng, Hsiaowei; Rosenthal, Norm; Jardine, Meg J.; Bakris, George; Perkovic, Vlado Journal: Circulation Issue: Volume 138:Issue 15(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Comment on "Comparative effectiveness of canagliflozin, SGLT2 inhibitors and non‐SGLT2 inhibitors on the risk of hospitalization for heart failure and amputation in patients with type 2 diabetes mellitus: A real‐world meta‐analysis of 4 observational databases (OBSERVE‐4D)". Issue 2 (20th September 2018) Authors: Ryan, Patrick B.; Rosenthal, Norm Journal: Diabetes, obesity & metabolism Issue: Volume 21:Issue 2(2019) Page Start: 444 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Comment on: Sodium‐glucose co‐transporter‐2 inhibitors and risk of adverse renal outcomes among type 2 diabetes patients: A network and cumulative meta‐analysis of randomized controlled trials. Issue 12 (21st July 2017) Authors: Canovatchel, William; Davidson, Jennifer; Rosenthal, Norm Journal: Diabetes, obesity & metabolism Issue: Volume 19:Issue 12(2017) Page Start: 1823 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Optimizing the analysis strategy for the CANVAS Program: A prespecified plan for the integrated analyses of the CANVAS and CANVAS‐R trials. Issue 7 (3rd April 2017) Authors: Neal, Bruce; Perkovic, Vlado; Mahaffey, Kenneth W.; Fulcher, Greg; Erondu, Ngozi; Desai, Mehul; Shaw, Wayne; Law, Gordon; Walton, Marc K.; Rosenthal, Norm; de Zeeuw, Dick; Matthews, David R. Journal: Diabetes, obesity & metabolism Issue: Volume 19:Issue 7(2017) Page Start: 926 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Renal safety of canagliflozin, a sodium glucose co‐transporter 2 inhibitor, in patients with type 2 diabetes mellitus. Issue 6 (16th March 2017) Authors: Desai, Mehul; Yavin, Yshai; Balis, Dainius; Sun, Don; Xie, John; Canovatchel, William; Rosenthal, Norm Journal: Diabetes, obesity & metabolism Issue: Volume 19:Issue 6(2017) Page Start: 897 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Risk of lower extremity amputations in people with type 2 diabetes mellitus treated with sodium‐glucose co‐transporter‐2 inhibitors in the USA: A retrospective cohort study. Issue 3 (11th October 2017) Authors: Yuan, Zhong; DeFalco, Frank J.; Ryan, Patrick B.; Schuemie, Martijn J.; Stang, Paul E.; Berlin, Jesse A.; Desai, Mehul; Rosenthal, Norm Journal: Diabetes, obesity & metabolism Issue: Volume 20:Issue 3(2018) Page Start: 582 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Sodium‐glucose co‐transporter‐2 inhibition and ocular outcomes in patients with type 2 diabetes: A systematic review and meta‐analysis. Issue 1 (13th October 2020) Authors: Li, Chao; Zhou, Zien; Neuen, Brendon L.; Yu, Jie; Huang, Yuli; Young, Tamara; Li, Jingwei; Li, Lin; Perkovic, Vlado; Jardine, Meg J.; Keay, Lisa; Markoulli, Maria; Rosenthal, Norm; Capuano, George; Yavin, Yshai; Neal, Bruce; Arnott, Clare Journal: Diabetes, obesity & metabolism Issue: Volume 23:Issue 1(2021) Page Start: 252 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗